We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Neuropathic

News List

FDA Approves First Generics of Lyrica drugs
July 23, 2019
The U.S. Food and Drug Administration approved multiple applications for first generics of Lyrica(pregabalin) for the management of neuropathic pain associated ...
New study analyzes cost effectiveness of smoked cannabis to treat chronic neuropathic pain worldpharmanews
January 31, 2019
Smoked cannabis as an adjunctive second-line therapy to treat chronic peripheral neuropathy can be both effective and cost-effective.
GB Sciences completes tech transfer of neuropathic pain formula .biospectrumasia
October 11, 2018
Singapore GB Sciences has completed the technology transfer for the manufacturing of time-released nanoparticles contain
Global Neuropathic Back Pain Epidemiology and Patient Flow Analysis 2018 biospace
April 19, 2018
The research provides insights into Neuropathic Back Pain epidemiology, Neuropathic Back Pain diagnosed patients, and Neuropathic Back Pain treatment rate for US, Japan, and EU5 countries.
Pharmaleads Reports Positive Phase I Data with PL265 for Treatment of Neuropathic Pain americanpharmaceuticalreview
June 30, 2017
Pharmaleads Reports Positive Phase I Data with PL265 for Treatment of Neuropathic Pain